2018 annual cancer treatment-related adverse events · chemotherapies, targeted therapies, and...
TRANSCRIPT
2018 ANNUALCancer Treatment-Related Adverse Events SYMPOSIUM
OCTOBER 26-27, 2018LIVE SIMULCAST
Memorial Sloan Kettering Cancer Center
Focus on Immunotherapies
Systemic anticancer therapies including cytotoxic chemotherapies, targeted therapies, and immunotherapies have resulted in improvements in patient survival. Despite this remarkable success, the majority of patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome. Therefore, prevention and management of untoward events is critical for the maintenance of quality of life and the optimization of anticancer therapies.
Target Audience
The target audience includes MDs, PAs, NPs, RNs, Pharmacists, and other professionals involved in the care of cancer patients.
Educational Objectives
• Recognize the clinical presentation, impact on qualityof life, and grading of treatment-related adverseevents in cancer patients
• Understand mechanisms and interventions to preventand treat acute and chronic adverse events in cancerpatients and survivors
• Discuss procedures and clinical tools to assesstreatment-related toxicities in cancer patients
2018 MSK ANNUALCancer Treatment-Related Adverse Events SYMPOSIUM
SYMPOSIUM HIGHLIGHTS
• Therapy-related adverse events will affectthe majority of patients, resulting in increasedcost, inconsistent dosing, and decreasedquality of life.
• With increased survival and patients livinglonger on therapy, adverse events affectingquality of life and clinical outcomecommand attention.
• This symposium provides up to dateinformation on adverse event mechanismsand management, from specialists in the mostcommonly affected organ systems.
• Practical strategies to maintain patients’quality of life and dose intensity will behighlighted for the most frequentlyoccurring events.
#MSKAdverseEventsCME
Mario E. Lacouture, MDMember, Memorial HospitalDermatology Service
Robin Mendelsohn, MDClinical Director, Gastroenterology, Hepatology and Nutrition ServiceCo-director, Center for Young Onset Colorectal CancerFellowship Director, Clinical Nutrition FellowshipMemorial Sloan Kettering Cancer CenterAssistant Professor of Clinical Medicine, Weill Cornell Medical Center
Saturday, October 27
Immunotherapy-Related Adverse Events Session IMODERATOR: Matthew Hellman, MD
8:00 am Welcome and Introduction Matthew Hellman, MD
8:15 am irAE and Quality of Life, Chronic irAEs Douglas Johnson, MD
8:45 am Immune-Related GI Adverse Events Michael Dougan, MD, PhD
9:15 am Immune-Related Cardiac Events Carol L. Chen, MD
9:45 am Panel Discussion All Faculty
10:00 am Break
Immunotherapy-Related Adverse Events Session IIMODERATOR: Monica Girotra, MD
10:30 am Endocrinopathies Monica Girotra, MD
11:00 am Immune-Related Pulmonary Events Vickie Shannon, MD
11:30 am Immune-Related Neurologic Events Bianca Santomasso, MD, PhD
12:00 pm Immune-Related Dermatologic Toxicities Mario E. Lacouture, MD
12:30 pm Immune-Related Rheumatic Disorders Laura Capelli, MD, MHS, MS
1:00 pm Panel Discussion All Faculty
1:15 pm Closing Remarks Mario E. Lacouture, MD
1:30 pm Adjourn
Laura Cappelli, MD, MHS, MSAssistant Professor of MedicineDepartment of MedicineDivision of Clinical and Molecular RheumatologyJohns Hopkins Medical Center
Mariana Castells, MD, PhDDirector, Drug Hypersensitivity and Desensitization CenterDirector, Mastocytosis CenterBrigham and Women’s HospitalProfessor of MedicineHarvard Medical School
Carol L. Chen, MDAssociate AttendingCardiology ServiceDepartment of Medicine
Kathryn Ciccolini, AGACNP-BC, NPHematology/Oncology ServiceMount Sinai Hospital/ Ruttenberg Cancer Center
Michael Dougan, MD, PhDDirector, Immunotherapy Mucosal Inflammation Program Division of GastroenterologyMassachusetts General Hospital
James Flory, MDAssistant Attending, Endocrine ServiceMemorial Sloan Kettering Cancer CenterAssistant ProfessorDepartment of Healthcare Policy and Research Weill Cornell Medical College
Shari B. Goldfarb, MDAssistant Attending, Breast Medicine ServiceMemorial Sloan Kettering Cancer Center
Korey Jaben, MDAssistant AttendingOphthalmic Oncology ServiceMemorial Sloan Kettering Cancer Center
Douglas Johnson, MDMember, Department of MedicineVanderbilt University Medical Center
Mark Kris, MDThe William and Joy Ruane Chair in Thoracic OncologyAttending Physician, Thoracic Oncology ServiceMemorial Sloan Kettering Cancer CenterProfessor, Weill Cornell Medical College
Rajesh Lalla, DDS, PhD, DABOMAssociate Professor, Oral Medicine Associate Dean for ResearchUConn Health
Nicole Leboeuf, MD, MPHClinical Director, Cutaneous Oncology Director, Program in Skin Toxicities for Anticancer Therapy Assistant Professor in DermatologyHarvard Medical SchoolDana-Farber Cancer Institute
Joannie Lefebvre, MD, FRCPCAssistant Professor of ClinicDepartment of MedicineNephrology DivisionHôpital Maisonneuve-RosemontUniversité de Montréal
Charles Loprinzi, MDConsultant, Division of Medical OncologyDepartment of OncologyMayo Clinic
Bianca Santomasso, MD, PhDMember, Neuro-Oncology ServiceMemorial Sloan Kettering Cancer Center
Florian Scotte, MD, PhDHead, Department of Medical Oncology and Supportive CareHopital Foch
Vickie Shannon, MDDirector of Pulmonary RehabilitationProfessor, Department of Pulmonary MedicineDivision of Internal Medicine MD Anderson Cancer Center
Mehak Sharma, MDMember, PsychiatryMemorial Sloan Kettering Cancer Center
Gerald Soff, MDChief, Hematology ServiceCo-Director, Hematology-Oncology FellowshipMemorial Sloan Kettering Cancer CenterProfessor of Clinical Medicine, Weill Cornell Medical College
Anthony Yu, MDAssistant AttendingCardiology Service Memorial Sloan Kettering Cancer Center
MSK Course Director
MSK Organizing Committee
Course Faculty
Monica Girotra, MDAssociate Clinical Member, Endocrinology Memorial Sloan Kettering Cancer Center
Matthew Hellman, MDMedical Oncologist, LungMemorial Sloan Kettering Cancer Center
LIVE SIMULCAST
All times are Eastern Standard Time (EST).
Friday, October 26
Cytotoxic and Targeted Therapies Session IMODERATOR: Robin Mendelsohn, MD
9:00 am Welcome and Introduction: Importance of Adverse Events
Mario E. Lacouture, MD
9:15 am Treatment-Related Adverse Event Research Florian Scotte, MD, PhD
9:45 am Adverse Event Triage and Acute Evaluations Kathryn Ciccolini, AGANCP-BC, NP
10:00 am Nausea and Vomiting Mark Kris, MD
10:25 am Diarrhea and Constipation Robin Mendelsohn, MD
10:50 am Break
11:15 am Nephrotoxicities Joannie Lefebvre, MD, FRCPC
11:40 am VTE and Treatment-Related Coagulopathies Gerald A. Soff, MD
12:10 pm Panel Discussion All Faculty
12:30 pm Lunch
Cytotoxic and Targeted Therapies Session IIMODERATOR: Mario E. Lacouture, MD
1:15 pm Hypersensitivity Reactions Mariana Castells, MD, PhD
1:45 pm Cardiac Toxicities Anthony Yu, MD
2:15 pm Chemotherapy Induced Peripheral Neuropathy Charles Loprinzi, MD
2:45 am Ocular Toxicities Korey Jaben, MD
3:15 pm Break
3:45 pm Sexual Dysfunction Shari B. Goldfarb, MD
4:05 pm Treatment-Related Psychiatric and Cognitive Disorders
Mehak Sharma, MD
4:35 pm Dermatologic Toxicities from Cytotoxic and Targeted Agents
Nicole Leboeuf, MD, MPH
5:05 pm Hyperglycemia and Cushing Disease James Flory, MD
5:30 pm Mucositis and Stomatitis Rajesh Lalla, DDS, PhD, DABOM
6:00 pm Panel Discussion All Faculty
6:15 pm Adjourn
Live Simulcast Rate $600
Register Online:
mskcc.org/AdverseEvents Detailed instructions will be emailed to attendees before the course and will include a link to the simulcast. Registration for this simulcast is non-refundable.
30% Discounted Rate for MSK Alumni and MSK Cancer Alliance Members: MSK offers a 30% discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact [email protected] for a promotion code or more information.
MSK Staff Registration: Registration is complimentary for MSK staff. However, you must register online: mskcc.org/AdverseEvents
ACCREDITATION STATEMENTMSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA CREDIT DESIGNATION STATEMENTMSK designates this live activity for a maximum of 12.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ABIM MOC RECOGNITION STATEMENTSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.50 Medical Knowledge MOC Points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit
FACULTY DISCLOSURE It is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it provides as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity provided by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.
CONTACTMemorial Sloan Kettering Cancer CenterOffice of Continuing Medical Education w:e:
mskcc.org/[email protected]
REGISTRATION